NCT05085496View on ClinicalTrials.gov

Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 19, 2022

Primary Completion Date

August 10, 2027

Study Completion Date

September 10, 2027

Conditions
Locally Advanced Skin Squamous Cell CarcinomaResectable Skin Squamous Cell CarcinomaUnresectable Skin Squamous Cell Carcinoma
Interventions
BIOLOGICAL

Atezolizumab

Given IV

RADIATION

Stereotactic Body Radiation Therapy

Undergo SBRT

Trial Locations (1)

91010

RECRUITING

City of Hope Medical Center, Duarte

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER